No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs17575455 |
chr2:76624220-76624221 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs112667268 |
chr2:76624231-76624232 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs73940411 |
chr2:76624268-76624269 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs571115034 |
chr2:76624323-76624324 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs548686597 |
chr2:76624338-76624339 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs139465959 |
chr2:76624340-76624341 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs375527790 |
chr2:76624357-76624358 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs181271619 |
chr2:76624382-76624383 |
Flanking Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs186730161 |
chr2:76624510-76624511 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs74942231 |
chr2:76624517-76624518 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs191419776 |
chr2:76624550-76624551 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs540142114 |
chr2:76624594-76624595 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs116156741 |
chr2:76624610-76624611 |
Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs573172222 |
chr2:76624632-76624633 |
Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs181966511 |
chr2:76624661-76624662 |
Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs561915582 |
chr2:76624690-76624691 |
Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs112999148 |
chr2:76624699-76624700 |
Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs544292990 |
chr2:76624702-76624703 |
Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs368684889 |
chr2:76624707-76624708 |
Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs186356204 |
chr2:76624720-76624721 |
Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs115012749 |
chr2:76624765-76624766 |
Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs544988886 |
chr2:76624916-76624917 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs147768332 |
chr2:76624923-76624924 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs527569637 |
chr2:76624941-76624942 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs549010006 |
chr2:76624946-76624947 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs191104533 |
chr2:76625014-76625015 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs376605031 |
chr2:76625028-76625029 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs549857258 |
chr2:76625032-76625033 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs13017817 |
chr2:76625060-76625061 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs539989017 |
chr2:76625094-76625095 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs10169401 |
chr2:76625113-76625114 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs528618138 |
chr2:76625160-76625161 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs548372528 |
chr2:76625167-76625168 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs534223517 |
chr2:76625246-76625247 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs368838025 |
chr2:76625247-76625248 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs77504030 |
chr2:76625324-76625325 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs372577733 |
chr2:76625344-76625345 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs183526460 |
chr2:76625407-76625408 |
ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs544319683 |
chr2:76625436-76625437 |
ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs556201657 |
chr2:76625445-76625446 |
ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs186777746 |
chr2:76625503-76625504 |
ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs191179644 |
chr2:76625572-76625573 |
ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs370854004 |
chr2:76625589-76625590 |
ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs560086110 |
chr2:76625671-76625672 |
ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs527624590 |
chr2:76625674-76625675 |
ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs139799610 |
chr2:76625681-76625682 |
ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs369310599 |
chr2:76625720-76625721 |
ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs73940412 |
chr2:76625738-76625739 |
ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs182799441 |
chr2:76625826-76625827 |
ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs145284061 |
chr2:76625858-76625859 |
ZNF genes & repeats
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|